Ache Laboratorios Farmaceuticos

Focus: Ache Laboratorios Farmaceuticos is a Brazilian-based pharmaceutical company specializing in small molecules and OTC products across neurology, respiratory, and dermatology. The company operates as a regional player with a substantial pipeline focused on combination therapies and established drug repurposing.

Neurology Respiratory Dermatology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Ache Laboratorios Farmaceuticos

AI assessmentNot Hiring

No open roles listed right now. Follow Ache Laboratorios Farmaceuticos to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

38 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Silicon-based products

Scars

N/A

Clinical Trials (1)

NCT02584010Efficacy Study of Two Silicon-based Products to Treat Scars

N/A

Help build intelligence for Ache Laboratorios Farmaceuticos

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Access to a diverse pipeline of 30 programs with 14 in Phase 3, offering broad exposure to drug development across multiple therapeutic areas
Opportunity to work on orphan/niche indications like vitiligo and benign prostatic hyperplasia with lower competitive pressure
Regional pharmaceutical company with established operations in Brazil's growing healthcare market

Watch Out For

Currently zero active job openings signals potential hiring freeze or organizational contraction
Heavy reliance on combination therapies and generics with limited novel mechanisms of action; no mAbs or advanced modalities
No disclosed financials, R&D spending, or revenue data limits visibility into company stability and growth trajectory

Generated by Claude from Ache Laboratorios Farmaceuticos's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

ACH15

Healthy

Phase 1

Clinical Trials (1)

NCT01702675Study to Assess Tolerability, Safety and Pharmacokinetics of a New Drug

Phase 1

ACH04

Diarrhea

Phase 1

Clinical Trials (1)

NCT02949089ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects

Phase 1

AS012

Non-segmental Vitiligo

Phase 2

Clinical Trials (1)

NCT04487860Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo

Phase 2

Melatonin

Insomnia Disorder

Phase 2/3

Clinical Trials (1)

NCT02798367Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of Insomnia

Phase 2/3

Paracetamol + Carisoprodol + Caffeine

Low Back Pain

Phase 3

DNN.65.21.005

Benign Prostatic Hyperplasia

Phase 3

Clinical Trials (1)

NCT07270432Efficacy/ Safety of Product DNN.65.21.005 in Patients With Benign Prostatic Hyperplasia

Phase 3

Levetiracetam

Epilepsy

Phase 3

Clinical Trials (1)

NCT01392768Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization

Phase 3

Rosuvastatin + Ezetimibe

Hypercholesterolemia

Phase 3

Acetaminophen + Caffeine + Dihydroergotamine + Metoclopramide

Migraine

Phase 3

Formoterol + Fluticasone

Chronic Obstructive Pulmonary Disease

Phase 3

Desloratadine + Phenylephrine + Ibuprofen

Cold

Phase 3

Budesonide + Formoterol

Asthma

Phase 3

Glucosamine Sulfate + Chondroitin Sulfate

Knee Osteoarthritis

Phase 3

Adapalene + Benzoyl Peroxide

Acne Vulgaris

Phase 3

Ketoconazole + Betamethasone

Tinea

Phase 3

CM9241GRU

Perennial Allergic Rhinitis

Phase 3

Clinical Trials (1)

NCT06577077Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis

Phase 3

Budesonide

Asthma

Phase 3

Clinical Trials (2)

NCT02853578Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled

Phase 3

NCT01676987Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma

Phase 3

Clotrimazole + Metronidazole

Vaginal Discharge

Phase 3

Clinical Trials (1)

NCT02713139Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies.

Phase 3

Dexamethasone

Acute Respiratory Distress Syndrome

Phase 3

Clinical Trials (1)

NCT04327401COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III

Phase 3

glucosamine sulfate /chondroitin sulfate - capsules

Knee Osteoarthritis

Phase 3

Clinical Trials (1)

NCT02010918Efficacy and Safety of Glucosamine Sulfate and Chondroitin Sulfate Combination in Treatment of Knee Osteoarthritis

Phase 3

Thermal Band

Low Back Pain

Phase 3

Clinical Trials (1)

NCT03508167Security and Efficacy of Dorilax® (Fixed Association of Paracetamol 350 mg, Carisoprodol 150 mg and Caffeine 50 mg) Plus Thermal Band Compared to Placebo Plus Thermal Band in the Treatment of Acute Low Back Pain.

Phase 3

Adapalene and Benzoyl peroxide Dalap Duo®

Acne Vulgaris

Phase 3

Clinical Trials (1)

NCT02716090Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris

Phase 3

Rosuvastatin 10 mg + Ezetimibe 10 mg and Rosuvastatin 20 mg + Ezetimibe 10 mg, according to clinical evaluation.

Hypercholesterolemia

Phase 3

Clinical Trials (1)

NCT01420549Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia

Phase 3

diphenhydramine + dropropizine + pseudoephedrine

Inflammation

Phase 3

Clinical Trials (1)

NCT01177852Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute Rhinitis

Phase 3

Desloratadine+Phenylephrine+Ibuprofen

Cold

Phase 3

Clinical Trials (1)

NCT02904304Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu

Phase 3

orphenadrine, acetaminophen, caffeine and diclofenac sodium

Postural Low Back Pain

Phase 3

Clinical Trials (1)

NCT02985671To Evaluate the Superiority of Fixed Combination (Orfenadrine 35mg, Acetaminophen 325mg, Caffeine 65mg and Diclofenac Sodium 50mg) Compared to Voltaren® (Diclofenac Sodium 50mg) in the Treatment of Acute Postural Low Back Pain.

Phase 3

Candicort®

Tinea

Phase 3

Clinical Trials (1)

NCT02582177Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis

Phase 3

Fixed-dose combination of naratriptan+naproxen

Migraine

Phase 3

Clinical Trials (1)

NCT01390324Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine

Phase 3

Acetaminophen+Caffeine+Dihydroergotamine+Metoclopramide.

Migraine

Phase 3

Clinical Trials (1)

NCT02582996Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks

Phase 3

Group 1

Nasal Congestion and Inflammations

Phase 3

Clinical Trials (1)

NCT01393561Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis

Phase 3

Bronpheniramine and fenilefrine

Common Cold

Phase 3

Clinical Trials (1)

NCT00967759Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper Respiratory Tract, in Children Between 2 and 6 Years Old

Phase 3

Placebo

Climacteric Syndrome

Phase 3

Clinical Trials (1)

NCT01695616Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric Symptoms

Phase 3

Cefaliv® & Placebo

Migraine Headache

Phase 3

Clinical Trials (1)

NCT02706015Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks

Phase 3

Combination Fluticasone /Formoterol 12/250 μg

Chronic Obstructive Pulmonary Disease

Phase 3

Clinical Trials (1)

NCT01393145Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD

Phase 3

ACH24

Vitiligo

Phase 3

Clinical Trials (1)

NCT01419964Efficacy and Safety of ACH24 in the Treatment of Vitiligo

Phase 3

Passiflora Incarnata + Isoflavone

Climacteric Syndrome

Phase 3

Diphenhydramine + Pseudoephedrine + Dropropizine

Nasal Congestion

Phase 3

Clinical Trials (1)

NCT01199497Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute Rhinitis

Phase 3

Brompheniramine + Phenylephrine

Common Cold

Phase 3

Clinical Trials (1)

NCT01393548Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis

Phase 3

Orphenadrine + Acetaminophen + Caffeine + Diclofenac Sodium

Postural Low Back Pain

Phase 3

Naratriptan + Naproxen

Migraine

Phase 3

Clinical Trials (1)

NCT01726920Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine.

Phase 3

Transpulmin

Cough

Phase 3

Clinical Trials (1)

NCT02581397Transpulmin Suppository and Guaiacol Compared to Transpulmin Syrup in Pediatric Participants With Productive Cough

Phase 3

Acetaminophen + Caffeine + Dihydroergotamine + Metoclopramide

Migraine

Phase 3

Somatropin

Healthy Subjects

Phase 4

Clinical Trials (1)

NCT03634514Non-inferiority Evaluation of Pain Intensity After Biomatrop (Somatropin) Application in Relation to Hormotrop (Somatropin), in Healthy Subjects

Phase 4

DNN.22.17.036

Alopecia

Phase 4

Clinical Trials (1)

NCT06355856Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss

Phase 4

Motore

Osteoarthritis, Knee

Phase 4

Clinical Trials (1)

NCT02409381Extract of Curcuma Longa Complexed With Phosphatidilcholine(Motore®)in the Treatment of Adults With Knee Osteoarthritis